Correlation Between Viking Therapeutics and Dogwood Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and Dogwood Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and Dogwood Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and Dogwood Therapeutics,, you can compare the effects of market volatilities on Viking Therapeutics and Dogwood Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of Dogwood Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and Dogwood Therapeutics,.
Diversification Opportunities for Viking Therapeutics and Dogwood Therapeutics,
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Viking and Dogwood is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and Dogwood Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dogwood Therapeutics, and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with Dogwood Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dogwood Therapeutics, has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and Dogwood Therapeutics, go up and down completely randomly.
Pair Corralation between Viking Therapeutics and Dogwood Therapeutics,
Given the investment horizon of 90 days Viking Therapeutics is expected to generate 0.34 times more return on investment than Dogwood Therapeutics,. However, Viking Therapeutics is 2.95 times less risky than Dogwood Therapeutics,. It trades about -0.25 of its potential returns per unit of risk. Dogwood Therapeutics, is currently generating about -0.09 per unit of risk. If you would invest 7,175 in Viking Therapeutics on August 31, 2024 and sell it today you would lose (1,724) from holding Viking Therapeutics or give up 24.03% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 95.65% |
Values | Daily Returns |
Viking Therapeutics vs. Dogwood Therapeutics,
Performance |
Timeline |
Viking Therapeutics |
Dogwood Therapeutics, |
Viking Therapeutics and Dogwood Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Viking Therapeutics and Dogwood Therapeutics,
The main advantage of trading using opposite Viking Therapeutics and Dogwood Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, Dogwood Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dogwood Therapeutics, will offset losses from the drop in Dogwood Therapeutics,'s long position.Viking Therapeutics vs. Cue Biopharma | Viking Therapeutics vs. Eliem Therapeutics | Viking Therapeutics vs. Inhibrx | Viking Therapeutics vs. Molecular Partners AG |
Dogwood Therapeutics, vs. Viracta Therapeutics | Dogwood Therapeutics, vs. Viking Therapeutics | Dogwood Therapeutics, vs. Dyadic International | Dogwood Therapeutics, vs. Surrozen Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |